EKSO:NASDAQ
Ekso Bionics Holdings Inc
11,79 US$
arrow_downward
−1,83%(−0,22) 1 d
11,96 US$
arrow_upward
+1,44% (+0,17)bedtimeEfter stängning
Stängd: 1 maj, 16:00:01 GMT−4 · USD
search
Alla symboler
1 d
5 d
1 m
6 m
Hittills i år
1 år
5 år
MAX
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för EKSO …
Öppen
12,26 US$
Högt
12,31 US$
Lågt
10,98 US$
Börsvärde
42,01 mn
Genomsn. vol.
73,11 tn
Volym
47,62 tn
52v högst
13,50 US$
52v lägst
2,75 US$
EPS
−4,91 US$
Beta
0,78
Utestående aktier
3,56 mn
Antal anställda
50
Nyheter och artiklar
Från källor på webben
kare11.com
·
för 3 dagar sedan
Ekso Bionics: Q1 Earnings Snapshot
Profil
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
Om Ekso Bionics Holdings Inc
VdScott Davis
Anställda50
Grundades2005
HuvudkontorSan Rafael, Kalifornien, USA
Sektor-
Webbplatseksobionics.com
AI-innehåll kan innehålla fel. Läs mer